CrunchBase is hiring! Check out our open positions →
Register | Login or Login

General Information

Websiteab-cam.com
Blogab-cam.com/blog
Twitter@abcam
CategoryBioTech
Phone01223696000
Emailorders@abcam.com
Employees350
Founded1998
DescriptionResearch tools for scientists

Offices

Abcam UK
330 Cambridge Science Park
Cambridge, CB4 0FL, GBR
Abcam USA
1 Kendall Square, Suite B2304
Cambridge, MA, 02139-1517
USA
Abcam Japan
Nihonbashi Kakigaracho
Chuo-ku
Tokyo , 1-16-8 , JPN

Acquisitions

Epitomics, 3/12

Tags

Abcam

Abcam is a producer and distributor of high quality research-grade antibodies and associated proteomics research products; antibodies are essential tools for life scientists that enable them to analyse components of living cells at the molecular level.

Since it was founded in 1998 by Dr. Jonathan Milner, Abcam has enjoyed rapid growth and is widely accredited as a leading company in its industry, with annualized turnover in excess of £60 million and growing. Headquartered in Cambridge (UK), Abcam has subsidiaries in Cambridge and Eugene (US), Tokyo (Japan) and Hong Kong (China), allowing them to serve a global customer base of over 75 countries. Abcam revolutionized the buying of antibodies via its website and their online catalogue consists of tens of thousands of products, supported by hundreds of thousands of pages of accompanying data. This includes a growing range of non-antibody products such as proteins, peptides, lysates, immunoassays and other kits, which will continue as the business expands in the broader protein detection and regulation market.

A key component in the success of Abcam comes from the speed with which it can bring products to market and it’s customer support efficiency. This enables scientists to find products with specific characteristics quickly, thus speeding up the pace of research into important diseases like cancer and coronary heart disease. Abcam’s in-house expertise means they are able to source products and supplementary resources for the newest and fastest growing research areas such as Cancer, Cardiovascular, Chromatin, Immunology, Neuroscience and Stem Cells.

Recent Milestones

Videos

Screenshots

Sources

  1. Abcam to buy Epitomics of San Francisco for $170M (marketwatch.com) [edit]
Edit This Page
Last Edited 10/24/12

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy